Objective
To determine whether fresh embryo transfers are at a higher risk of abnormal implantation compared to frozen embryo transfers while accounting for the embryo stage at transfer.
Design
Retrospective cohort study.
Patients
We used data from the Society for Assisted Reproductive Technologies (SART) to identify all fresh and frozen autologous IVF cycles from 2004–2013 resulting in a positive pregnancy test. The cycles were parameterized into a four-level predictor of 1) fresh blastocyst transfer, 2) fresh non-blastocyst transfer, 3) frozen blastocyst transfer, and 4) frozen non-blastocyst transfer.
Intervention
None.
Main Outcome Measure
We examined a composite outcome of abnormal implantation, defined as biochemical pregnancy, ectopic/heterotopic pregnancy, and first trimester pregnancy loss. Regression modeling was performed with repeated measures multivariable logistic regression, adjusted for age, parity, number of embryos transferred, infertility diagnosis, and calendar year of treatment.
Results
Of 509,938 cycles analyzed, 31.8% resulted in abnormal implantation. Compared to a fresh blastocyst transfer, a fresh non-blastocyst transfer had a 22% increase risk of abnormal implantation, a frozen blastocyst transfer had a 36% increase risk, and a frozen non-blastocyst transfer had a 57% increase risk. When individual outcomes were analyzed, fresh embryo transfers had a lower risk of biochemical pregnancy and pregnancy loss, but a higher risk for ectopic/heterotopic pregnancy.
Conclusion
Fresh blastocyst transfers had the lowest overall risk of abnormal implantation, but a higher risk of ectopic/heterotopic pregnancy. Although embryo cryopreservation is indicated in certain treatment cycles, elective embryo cryopreservation may not be the optimal strategy to adopt for all cycles.